세계의 자동 세포 진탕기 시장 규모는 예측 기간인 2025-2032년에 6.34%의 CAGR로 확대하며, 2024년 7억 112만 달러에서 2032년에는 11억 4,811만 달러로 성장할 것으로 예측됩니다. 첨단 실험실 자동화 시스템에 대한 수요가 증가함에 따라 자동 셀 셰이커의 채택이 크게 증가하고 있습니다.
생명공학 및 제약 연구실은 연구센터와 함께 자동 세포진동기의 지속적인 시장 확대를 주도하고 있습니다. 이 장비는 세포배양 작업 중 성장 환경을 최적화하기 위해 제어된 진동을 제공함으로써 세포배양 작업 중 필수적인 장비로 작용합니다. 자동가진기는 자동화를 통해 수동 모델보다 우수한 성능을 발휘하여 작업자의 실수를 최소화하고 광범위한 제조 작업을 지원합니다. 시장 개발의 원동력은 세포 기반 연구개발과 바이오의약품에 대한 자금 지원 증가, 그리고 일관된 성과에 대한 요구라는 세 가지 요소로 구성됩니다.
이 장비는 프로그램 가능한 제어와 실시간 추적을 통해 스마트한 기능을 구현하고 실험실 정보 시스템과의 통합을 가능하게 합니다. 북미와 유럽은 연구 인프라가 잘 발달되어 있으며, 시장이 가장 높은 수준에 도달한 반면, 아시아태평양은 바이오 산업의 확대로 인해 시장 성장을 주도하고 있습니다. 시장 리더들은 에너지 효율적인 설계와 용기 호환성을 갖춘 모듈식 요소를 결합한 신제품 출시에 자원을 투입하고 있습니다. 자동 세포진탕기 시장은 기술 발전과 의약품 개발 및 합성 생물학 분야에서의 용도 확대로 인해 지속적으로 성장하고 있습니다. 또한 각 업체들은 자동 세포진탕기 시장을 지원하기 위해 협력하고 있습니다.
예를 들어 2023년 5월, Cytiva Bioscience Holding Ltd.는 Pall Corporation Life Science와의 제휴를 발표하여 세계 생명공학 혁신 리더를 설립했습니다. 이번 합병을 통해 회사의 바이오프로세스 역량을 확장하고 생물제제 및 백신 개발을 지원할 수 있는 역량을 강화했습니다. 이 전략적 결정은 생명공학 산업에서 회사 시장 지위를 향상시키고 혁신의 속도와 경영 효율성을 모두 향상시킬 수 있는 전략적 결정입니다.
세계의 자동 세포 진탕기 시장에 대해 조사했으며, 시장의 개요와 제품 유형별, 주파수 대역별, 용도별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.
Global automated cell shakers market is projected to witness a CAGR of 6.34% during the forecast period 2025-2032, growing from USD 701.12 million in 2024 to USD 1148.11 million in 2032. The increasing demand for advanced laboratory automation systems is significantly boosting the adoption of automated cell shakers.
Biotechnology and pharmaceutical research laboratories, together with research centers, drive consistent market expansion for automated cell shaker equipment. These devices serve as essential instruments during cell culture operations by delivering controlled shaking to optimize growth environments. Automated shakers deliver superior performance compared to manual models through automation, which minimizes operator mistakes and supports extensive manufacturing operations. Three main factors drive market expansion: developments in cell-based research and rising biopharmaceutical funding and the requirement for consistent outcomes.
The devices enable smart functions through programmable controls and real-time tracking coupled with laboratory information system integration. The market reaches its highest level in North America and Europe because of their advanced research infrastructure, yet Asia-Pacific leads to market growth with its expanding biotech industry. The market leaders invest their resources into releasing new products that combine modular elements with energy-efficient designs and vessel compatibility. The automated cell shaker market continues to grow because of technological advancements and expanding applications in drug development and synthetic biology. Additionally, the companies are collaborating to support the automated cell shakers market.
For instance, in May 2023, Cytiva Bioscience Holding Ltd. announced a collaboration with Pall Corporation Life Science to establish a worldwide biotechnology innovation leader. The merger expanded their bioprocessing abilities, which boosted their ability to support biologics and vaccine development. The strategic decision enhanced their market standing within biotechnology, which drove both innovation speed and operational effectiveness.
Rising Demand for Cell-Based Research Boosts Market Demand
The rising demand for cell-based research in drug development, biotechnology, and regenerative medicine is significantly boosting the market shares of automated cell shakers. Cell culture applications depend on these devices to maintain uniform agitation and optimal nutrient flow, which enhances cell survival necessary for drug discovery, vaccine creation, and regenerative medicine procedures. High-throughput screening and precision-based studies within research facilities require automated cell shakers, as these devices deliver enhanced efficiency and reproducible results while minimizing contamination compared to the manual method. Programmable controls, compact designs, and lab automation integration systems drive higher adoption rates. The automated cell shaker market is expected to sustain its growth through rising R&D investments and the expansion of biological production, capturing a larger share of the life sciences equipment sector.
Additionally, the research study and clinical trials can also boost the demand for the automated cell shakers market. For instance, in March 2024, the Society for Laboratory Automation and Screening (SLAS) researched Skin Cutaneous Melanoma Prognosis, Nanoliter Droplet Handling for Enhanced Laboratory Efficiency, and other areas of life science technology. This research activity increased the demand for cell shakers.
Increasing Adoption of Laboratory Automation Drives Market Expansion
The rapid expansion of laboratory automation drives the growth of the automated cell shaker market at a fast pace. Global laboratories that strive for enhanced efficiency, accuracy, and reproducibility require automated solutions as essential tools. Automated shakers used in cell culture workflows remove operator dependence, so they minimize human mistakes while maintaining consistent shaking conditions. The need to perform high-throughput screening in drug discovery, as well as biotechnology and academic research, drives substantial market expansion. Automated systems enable laboratories to enhance process efficiency while reducing costs and boosting their productivity levels. Automated cell shakers gain market preference because technological progress enables programmable speed functions with temperature control and remote monitoring features. The market experiences fast expansion because biopharmaceutical research expands, and organizations need scalable solutions. The automated cell shaker market experiences rapid growth because laboratories pursue precision and efficiency, while new technologies emerge and laboratory automation expands across the industry. For instance, in September 2023, Kuhner Shaker launched new white versions of its LT-X(C) and ISF4-X(C) incubator shaker models, catering to aesthetic preferences and expanding their product portfolio to appeal to a broader user base. The new launches have driven laboratories to adopt automatic cell shakers because diagnostic centers now use advanced technology for enhanced quality.
Pharmaceutical Companies and Biopharmaceutical Companies Hold Largest Market Shares
Pharmaceutical and biopharmaceutical companies hold the largest market shares of the automated cell shakers market. The precise and scalable nature of automated cell shakers meet the pharmaceutical industry's rising demand for efficient cell culture processes during drug development and bioprocessing. Through automated cell shakers, companies boost their productivity levels because these devices deliver steady agitation and optimal growth conditions while minimizing contamination risks. These sectors allocate substantial capital toward purchasing modern laboratory equipment to optimize their research and production activities, to lead market expansion. The implementation of strict regulatory requirements creates an increased need for dependable automatic systems, which drives market growth. The growing biopharmaceutical market, especially those focused on biologics and cell-based treatments, strengthens this ongoing development. Pharmaceutical and biopharmaceutical companies maintain their market dominance through rapid innovation, which drives their continued adoption of automated cell shakers.
For instance, in October 2024, Eppendorf introduced the CellXpert CS220, the first CO2 incubator shaker with a built-in 180 degrees Celsius sterilisation cycle. Tailored for mammalian cell cultivation, enhanced contamination prevention, accommodated more flasks, and included a streamlined chamber for simplified cleaning. The device also showcased a compact design, delivering the highest platform-to-footprint ratio.
North America Dominates the Global Automated Cell Shakers Market Size
North America dominates the automated cell shakers market, holding the largest share due to advanced healthcare systems, the presence of major industry players, and strong research funding. The rising popularity of biopharmaceuticals, cell culture technologies, and laboratory automation drives the region's expansion. The United States leads the market due to its superior research capabilities combined with broad technological implementation and large life science capital. The growing market receives extra support for its increasing focus on drug development and regenerative medicine applications. The Canadian government supports its biotech industry through its official programs that promote development activities. Research facilities, clinical settings, and industrial labs are increasing their use of automated cell shakers to emphasize a precision medicine approach and personalized therapy development. Research organizations, together with pharmaceutical companies, create partnerships to advance technological development in North America. The regulatory systems across North America favor innovative approaches as they maintain quality standards to protect the market's leadership standing.
Furthermore, to support market expansion in this region, key players in this region are launching new products. For instance, in March 2025, Caron Scientific Inc. launched the 7406 Incubator Shaker at the EU Advanced Therapies conference. The unit featured the highest capacity in a compact footprint, H2O2 fogging sterilization, and a dry humidity control system without standing water. It offered faster turnaround, minimized contamination risks, and efficiently met GMP compliance needs.
Impact of U.S. Tariffs on the Global Automated Cell Shakers Market
The U.S. tariffs on imported merchandise specifically affect the automated cell shakers market through their impact on Chinese products. The essential biotechnology and pharmaceutical research equipment, known as automated cell shakers, needs global supply chains to achieve cost-effective production. The implementation of tariffs has driven up costs for United States buyers, decreasing the affordability of equipment for laboratory facilities and research establishments. The rising costs of imported components create pressure on the profit margins of domestic manufacturers. Businesses that need to switch to non-tariff countries for sourcing will experience supply chain disruptions because it requires both time and financial investment. Small businesses face the most significant impact from tariffs because they cannot negotiate effectively, which limits their ability to innovate. Tariffs increase the appeal of domestic production, yet the United States does not possess sufficient manufacturing capacity to fulfill market requirements. The tariffs create budget constraints while slowing research progress and generating market instability, which results in reduced market development. The current protectionist approach creates a challenging situation that may slow down the vital biotechnology sector.
Key Players Landscape and Outlook
Companies are expanding their market footprint via product development and automated system implementation, along with improved user-centered design approaches. Companies pursue their growth objectives by creating models that handle large volumes efficiently while conserving energy and by making their products compatible with laboratory automation systems. The industry shows positive prospects because AI-based optimization systems, together with remote monitoring capabilities and modular design approaches, are defining future market directions. The increasing market rivalry drives producers to develop precise, scalable products at affordable prices that match multiple laboratory requirements.
In June 2024, Thermo Fisher Scientific Inc. launched the fully integrated IntelliStack Incubator and CO2 Incubator Shakers for precise and reproducible cell culture control. The stackable units featured a 10-inch touchscreen, 5L capacity, and flexible configurations with CO2 and non-CO2 shakers. The solution targets biotech, biopharma, and academic sectors, supports automated cell therapy production, and addresses contamination risks.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.